Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma.
Grace Lai-Hung WongVicki Wing-Ki HuiTerry Cheuk Fung YipLilian Yan LiangXinrong ZhangYee-Kit TseJimmy Che-To LaiHenry Lik Yuen ChanVincent Wai-Sun WongPublished in: Alimentary pharmacology & therapeutics (2022)
Universal HBV vaccination markedly reduces the prevalence of chronic HBV infection and may contribute to the decreased incidences of HCC and hepatic events.